Last updated: April 26, 2026
Benzphetamine hydrochloride is a controlled, mono-amine releasing agent used in the treatment of obesity. It is commonly supplied as an active pharmaceutical ingredient (API) under contract manufacturing and API distribution channels. Supplier lists are typically composed of API manufacturers and authorized distributors, with sourcing controlled by quality and regulatory constraints (e.g., DMF/ASMF availability, GMP status, and licensure).
Who supplies benzphetamine hydrochloride (API) in practice?
Across global sourcing networks, benzphetamine hydrochloride is supplied via three route types:
- Direct API manufacturers (GMP): Firms that produce benzphetamine hydrochloride bulk API under GMP and provide DMF/ASMF documentation where applicable.
- API traders and distributors: Licensed resellers that procure from manufacturers and provide documentation packages to buyers.
- Specialty contract manufacturers (on-demand): Smaller supply base that can support packaging, relabeling, or limited batch production depending on market demand.
Which manufacturing and trading categories hold the product?
| Supply channel |
What they typically provide |
Typical buyer use |
| API manufacturer |
GMP CoA, impurity profile, DMF/ASMF linkage where available |
Direct commercial sourcing, ANDA/clinical supply |
| Authorized distributor |
Manufacturer sourcing chain, CoA, handling documentation |
Stable procurement, multi-country fulfillment |
| Contract manufacturing |
Custom packaging/labeling, batch support |
Back-up supply, pilot-to-commercial bridging |
How do buyers usually validate benzphetamine hydrochloride suppliers?
Suppliers for controlled APIs are usually vetted on the following hard requirements:
| Validation item |
What procurement expects |
| Regulatory dossier |
DMF/ASMF or equivalent regulatory documentation traceability |
| GMP status |
Current GMP certificate for relevant operations |
| Quality system |
CoA, specification sheet, impurity profile, stability data where applicable |
| Controlled substance compliance |
Licensing, permitted storage/transport, recordkeeping |
| Supply chain |
Lot traceability, change control history, re-test/shelf-life policies |
What due diligence documents do suppliers provide?
A standard benzphetamine hydrochloride supplier documentation set typically includes:
- Certificate of Analysis (CoA) per lot
- Specification sheet for identity, assay, impurities, and residual solvents
- GMP certificate for manufacturing site(s) and packing site(s)
- DMF/ASMF letter of access or dossier referencing (if applicable in that buyer’s regulatory environment)
- Traceability and packaging configuration details
- Controlled-substance handling documentation (where required by destination country)
Where does benzphetamine hydrochloride typically appear on supplier product catalogs?
In practice, benzphetamine hydrochloride is most visible through:
- API catalogs marketed by trading/distribution groups
- GMP API lists tied to specific DMF/ASMF frameworks
- Clinical supply or controlled-substance supply portals used by specialized procurement teams
Supplier discovery constraints for this specific API
Benzphetamine hydrochloride is a controlled active ingredient in many jurisdictions. That changes how suppliers list and advertise product availability, and it often limits public catalog completeness. As a result, supplier availability and authorization can vary by:
- destination country licensing status
- customer type (manufacturer vs. distributor vs. hospital pharmacy)
- current quota and shipment scheduling
- whether the supplier is prepared to support dossier linkage
Key sourcing strategy for benzphetamine hydrochloride
Procurement teams typically run a two-track approach:
- Primary sourcing from a manufacturer or distributor with complete dossier and CoA support.
- Secondary sourcing from a backup distributor that can move product quickly while meeting controlled-substance handling requirements.
Supplier categories to prioritize (based on procurement efficiency)
| Priority |
Supplier type |
Reason procurement prioritizes it |
| 1 |
GMP API manufacturer with dossier linkage |
Faster regulatory alignment and fewer upstream change risks |
| 2 |
Authorized distributor with strong documentation packages |
Faster lead time and practical logistics support |
| 3 |
Small contract/spot suppliers |
Possible cost advantage, but higher variability and documentation risk |
Key Takeaways
- Benzphetamine hydrochloride is sourced through GMP API manufacturers, authorized distributors, and controlled-substance-capable trading networks.
- Procurement focuses on dossier linkage (DMF/ASMF or equivalent), lot-by-lot CoA, GMP certification, impurity/spec compliance, and controlled substance logistics readiness.
- Public supplier lists are often incomplete for controlled APIs; practical sourcing relies on documentation capability and licensed distribution routes.
FAQs
1. Do all benzphetamine hydrochloride “API” listings come from GMP manufacturers?
No. Many listings are from distributors or traders who source from manufacturer sites. Buyers usually verify GMP certificates tied to the manufacturing site and request dossier documentation.
2. What should a buyer require in a CoA for benzphetamine hydrochloride?
A CoA per lot typically includes identity confirmation, assay, impurity profile, and compliance with the supplier’s agreed specifications, plus batch/lot traceability.
3. Can suppliers provide DMF/ASMF information for benzphetamine hydrochloride?
Often yes via manufacturer-controlled dossier frameworks, but access depends on the supplier’s regulatory position and the buyer’s regulatory region.
4. How do controlled-substance requirements affect procurement?
They affect who can buy, store, and ship, and they require licensed handling, documentation, and recordkeeping in the destination jurisdiction.
5. What is the fastest path to secure supply?
Use suppliers that already support dossier-ready documentation and controlled-substance compliant logistics, then qualify a second distributor for continuity.
- U.S. Food and Drug Administration (FDA). “Controlled Substances.” https://www.fda.gov/drugs/investigational-new-drugs/controlled-substances
- U.S. Drug Enforcement Administration (DEA). “Controlled Substances Act.” https://www.dea.gov/controlled-substances-act
- International Council for Harmonisation (ICH). “ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients.” https://www.ich.org/page/quality-guidelines
